The development of RT-QuIC with tau K12CFh synthetic tau fragment enabled one assay to detect and discriminate (by differing ThT fluorescence maxima) 3R seeds of Pick’s disease and 3R/4R seeds of CTE and AD brain homogenate (Metrick et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.